You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API RISEDRONATE SODIUM


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing RISEDRONATE SODIUM

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc ACTONEL risedronate sodium 0430-0471 CELLULOSE, MICROCRYSTALLINE
Allergan Inc ACTONEL risedronate sodium 0430-0471 CROSPOVIDONE
Allergan Inc ACTONEL risedronate sodium 0430-0471 FERRIC OXIDE YELLOW
Allergan Inc ACTONEL risedronate sodium 0430-0471 HYDROXYPROPYL CELLULOSE
Allergan Inc ACTONEL risedronate sodium 0430-0471 HYPROMELLOSES
Allergan Inc ACTONEL risedronate sodium 0430-0471 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing RISEDRONATE SODIUM

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc risedronate sodium 0093-3099 D&C YELLOW NO. 10
Teva Pharmaceuticals USA Inc risedronate sodium 0093-3099 FERRIC OXIDE YELLOW
Teva Pharmaceuticals USA Inc risedronate sodium 0093-3099 HYPROMELLOSE 2910
Teva Pharmaceuticals USA Inc risedronate sodium 0093-3099 LACTOSE MONOHYDRATE
Teva Pharmaceuticals USA Inc risedronate sodium 0093-3099 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc risedronate sodium 0093-3099 POLYETHYLENE GLYCOL 400
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for RISEDRONATE SODIUM

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: EDETATE DISODIUM

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

RISEDRONATE SODIUM drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Teva Pharmaceuticals USA Inc risedronate sodium 0093-3099
Teva Pharmaceuticals USA Inc risedronate sodium 0093-7771
Allergan Inc risedronate sodium 0430-0471
Allergan Inc risedronate sodium 0430-0979
Actavis Pharma Inc risedronate sodium 0591-2102
Macleods Pharmaceuticals Limited risedronate sodium 33342-107
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

RISEDRONATE SODIUM drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Company Ingredient NDC
Teva Pharmaceuticals USA Inc risedronate sodium 0093-3099
Teva Pharmaceuticals USA Inc risedronate sodium 0093-7771
Allergan Inc risedronate sodium 0430-0471
Actavis Pharma Inc risedronate sodium 0591-2102
NorthStar RxLLC risedronate sodium 16714-870
Macleods Pharmaceuticals Limited risedronate sodium 33342-107
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

RISEDRONATE SODIUM drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
NorthStar RxLLC risedronate sodium 16714-870
Greenstone LLC risedronate sodium 59762-0407
Sun Pharmaceutical Industires Inc risedronate sodium 63304-440
Zydus Pharmaceuticals USA Inc risedronate sodium 68382-075
Zydus Lifesciences Limited risedronate sodium 70771-1436
Impax Generics risedronate sodium hemi-pentahydrate 0115-1426
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group